Advocacy intelligence hub — real-time data for patient organizations
Michael Rafii, MD, PhD — PHASE4
Northwestern University — NA
Ohio State University — PHASE2
National Institute of Allergy and Infectious Diseases (NIAID)
Brigham and Women's Hospital — PHASE1
Riphah International University — NA
Sumitomo Pharma America, Inc. — PHASE1
UNC Lineberger Comprehensive Cancer Center — NA
Hospices Civils de Lyon
Beni-Suef University — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Akito Hirakata, MD
Kyroin University
Priya Kishnani, MD
Duke University
📍 DURHAM, NC
Jeffrey Taub, MD, CRNA
Children's Oncology Group
📍 FLINT, MI
Charles W Gorodetzky, MD, PhD, M.D., Ph.D
Chief Medical Officer
📍 KANSAS CITY, MO
Amy J Sehnert, MD, MD
Verinata Health, Inc.
📍 PALO ALTO, CA
Joaquin Espinosa, PhD
Linda Crnic Institute, University of Colorado Anschutz Medical Campus